| Literature DB >> 2413452 |
A A Ythier, M Abbud-Filho, J M Williams, R Loertscher, M W Schuster, A Nowill, J A Hansen, D Maltezos, T B Strom.
Abstract
We have isolated and studied two alloreactive, T4+, human lymphocyte clones that release interleukin 2 (IL-2) and interleukin 3 (IL-3) bioactivities upon stimulation with IL-2, alloantigen, or Sepharose-conjugated antibodies directed against the T3 protein. Anti-IL-2 receptor monoclonal antibodies block IL-2-, alloantigen-, or anti-T3-stimulated IL-3 release. Hence, release of IL-3 activity in each circumstance is rigorously dependent upon activation of the IL-2 receptor. Even low, nonmitogenic concentrations of recombinant IL-2 stimulated IL-3 release.Entities:
Mesh:
Substances:
Year: 1985 PMID: 2413452 PMCID: PMC391301 DOI: 10.1073/pnas.82.20.7020
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205